Rafael Holdings, Inc. (RFL): Total Liabilities
$11.09M
As of 2026-07-31
+71.4%
3-year compound annual growth
-8.6%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2026-07-31 | $11.09M | -29.6% | 2026-10-29, Balance as of period end |
| 2025-07-31 | $15.74M | +48.8% | 2026-10-29, Balance as of period end |
| 2024-07-31 | $10.57M | +380.6% | 2025-10-29, Balance as of period end |
| 2023-07-31 | $2.20M | -89.6% | 2024-12-20, Balance as of period end |
| 2022-07-31 | $21.11M | +21.7% | 2023-10-30, Balance as of period end |
| 2021-07-31 | $17.35M | +198.2% | 2022-10-31, Balance as of period end |
| 2020-07-31 | $5.82M | -66.5% | 2021-10-18, Balance as of period end |
| 2019-07-31 | $17.38M | n/m | 2020-10-29, Balance as of period end |
| 2018-07-31 | $1.35M | -94.4% | 2019-10-04, Balance as of period end |
| 2017-07-31 | $24.13M | n/a | 2018-10-15, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | 2026-07-31 | $11.09M | -29.6% |
| Rallybio Corp (RLYB) | 2025-12-31 | $4.30M | -33.3% |
| Onconetix, Inc. (ONCO) | 2025-12-31 | $9.16M | -50.7% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $8.64M | -24.4% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $1.99M | +10.1% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $29.63M | +5.4% |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $1.57M | +30.1% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $5.05M | -18.9% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $4.11M | -57.1% |
Compare RFL, RLYB, ONCO, STTK side by side · Screen every company in Pharmaceutical Preparations ↗